206 Results for "

second-generation

" in MedChemExpress (MCE) Product Catalog:
Products (206)

206 Results for "second-generation" in MCE Product Catalog:

2
2 Cited Publications
Art. -Nr.: HY-156654
CAS. Nr.: 2755812-39-4
Reinheit:  99.90%
Synonyms: PF-07817883
Target:  

SARS-CoV Virus Protease

Forschungsgebiete:  

Infection

Ibuzatrelvir (PF-07817883), a second-generation, orally bioavailable, is SARS-CoV-2 main protease (M pro and 3CL pro) inhibitor with improved metabolic stability. Ibuzatrelvir has demonstrated pan-human coronavirus antiviral activity and off-target selectivity profile in vitro and in preclinical animal studies. Ibuzatrelvir is well tolerated with a safety profile similar to placebo and prevents viral infection and transmission. Ibuzatrelvir can be used to inhibit COVID-19 .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-18340
CAS. Nr.: 294646-77-8
Synonyms: CR8, (R)-Isomer
Forschungsgebiete:  

Neurological Disease Cancer

(R)-CR8, a second-generation analog of Roscovitine, is a potent CDK1/2/5/7/9 inhibitor. (R)-CR8 inhibits CDK1/cyclin B (IC50=0.09 μM), CDK2/cyclin A (0.072 μM), CDK2/cyclin E (0.041 μM), CDK5/p25 (0.11 μM), CDK7/cyclin H (1.1 μM), CDK9/cyclin T (0.18 μM) and CK1δ/ε (0.4 μM). (R)-CR8 induces apoptosis and has neuroprotective effect . (R)-CR8 acts as a molecular glue degrader that depletes cyclin K .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-18340A
CAS. Nr.: 1786438-30-9
Synonyms: CR8, (R)-Isomer trihydrochloride
Forschungsgebiete:  

Neurological Disease Cancer

(R)-CR8 (CR8) trihydrochloride, a second-generation analog of Roscovitine, is a potent CDK1/2/5/7/9 inhibitor. (R)-CR8 trihydrochloride inhibits CDK1/cyclin B (IC50=0.09 μM), CDK2/cyclin A (0.072 μM), CDK2/cyclin E (0.041 μM), CDK5/p25 (0.11 μM), CDK7/cyclin H (1.1 μM), CDK9/cyclin T (0.18 μM) and CK1δ/ε (0.4 μM). (R)-CR8 trihydrochloride induces apoptosis and has neuroprotective effect . (R)-CR8 trihydrochloride acts as a molecular glue degrader that depletes cyclin K .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B0674
CAS. Nr.: 90729-43-4
Synonyms: LAS-W 090; RP64305
Target:  

Histamine Receptor

Forschungsgebiete:  

Inflammation/Immunology Endocrinology

Ebastine (LAS-W 090) is an orally active, second-generation histamine H1 receptor antagonist. Ebastine can be used for the symptoms of allergic rhinitis and chronic idiopathic urticaria research .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-A0015
CAS. Nr.: 190786-44-8
Bepotastine besilate is a selective and orally active second-generation histamine H1 receptor antagonist, can suppress the expression of nerve growth factor (NGF). Bepotastine besilate has the potential for allergic rhinitis, allergic conjunctivitis and urticaria/pruritus research .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B0797
CAS. Nr.: 54350-48-0
Synonyms: Ro 10-9359
Target:  

Apoptosis

Forschungsgebiete:  

Others

Etretinate(Ro 10-9359) is a second-generation retinoid that has the potential for severe psoriasis treatment.
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-I0021
CAS. Nr.: 125602-71-3
Target:  

Histamine Receptor

Forschungsgebiete:  

Inflammation/Immunology Endocrinology

Bepotastine is a selective and orally active second-generation histamine H1 receptor antagonist, can suppress the expression of nerve growth factor (NGF). Bepotastine has the potential for allergic rhinitis, allergic conjunctivitis and urticaria/pruritus research .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-G0014A
CAS. Nr.: 329218-11-3
Synonyms: Quetiapine S-oxide dihydrochloride
Target:  

Drug Metabolite

Forschungsgebiete:  

Neurological Disease

Quetiapine sulfoxide dihydrochloride (Quetiapine S-oxide dihydrochloride) is a main metabolite of Quetiapinem. Quetiapine is a second-generation antipsychotic . Quetiapine is a 5-HT receptors agonist and a dopamine receptor antagonist .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-10449A
CAS. Nr.: 1152425-66-5
Reinheit:  99.20%
Synonyms: TS 071 hydrate
Target:  

SGLT

Forschungsgebiete:  

Metabolic Disease

Luseogliflozin (TS 071) hydrate is a selective potent and orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor with an IC50 of 2.26 nM. Luseogliflozin hydrate can be used for the research of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-118643
CAS. Nr.: 1620330-72-4
Reinheit:  99.82%
Synonyms: BMS-986231; CXL-1427
Target:  

Drug Intermediate

Forschungsgebiete:  

Cardiovascular Disease

Cimlanod (BMS-986231) is a second-generation Nitroxyl (HNO) donor for heart failure. Cimlanod (BMS-986231) delivers HNO via pH-dependent chemical breakdown when exposed to the neutral pH environment of the bloodstream. Cimlanod (BMS-986231) possesses positive lusitropic and inotropic as well as vasodilatory effects. Cimlanod is the prodrug of CXL-1020 (HY-147384) .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B0012
CAS. Nr.: 40391-99-9
Pamidronic acid, the second-generation nitrogen-containing bisphosphonate, is an inhibitor of bone loss. Pamidronic acid significantly inhibits subchondral bone loss in early osteoarthritis by upregulating the expression of OPG in cartilage and subchondral bone, and inhibiting the expression of RANKL and MMP-9 in both tissues, as well as TLR-4 in cartilage, thereby alleviating cartilage degeneration. Additionally, Pamidronic acid can inhibit the signaling of Wnt and β-catenin, and is applicable for research on osteoporosis and osteosarcoma .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B0012A
CAS. Nr.: 57248-88-1
Synonyms: CGP 23339A
Pamidronate disodium (CGP 23339A), the second-generation nitrogen-containing bisphosphonate, is an inhibitor of bone loss. Pamidronate disodium significantly inhibits subchondral bone loss in early osteoarthritis by upregulating the expression of osteoprotegerin in cartilage and subchondral bone, and inhibiting the expression of RANKL and MMP-9 in both tissues, as well as TLR-4 in cartilage, thereby alleviating cartilage degeneration. Additionally, Pamidronate disodium can inhibit the signaling of Wnt and β-catenin, and is applicable for research on osteoporosis and osteosarcoma .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B0730
CAS. Nr.: 109552-15-0
Pamidronate disodium pentahydrate, the second-generation nitrogen-containing bisphosphonate, is an inhibitor of bone loss. Pamidronate disodium pentahydrate significantly inhibits subchondral bone loss in early osteoarthritis by upregulating the expression of osteoprotegerin in cartilage and subchondral bone, and inhibiting the expression of RANKL and MMP-9 in both tissues, as well as TLR-4 in cartilage, thereby alleviating cartilage degeneration. Additionally, Pamidronate disodium pentahydrate can inhibit the signaling of Wnt and β-catenin, and is applicable for research on osteoporosis and osteosarcoma .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-130252
CAS. Nr.: 2454246-18-3
Reinheit:  99.83%
YQ128 is a potent and selective second-generation NLRP3 (NOD-like receptor P3) inflammasome inhibitor with an IC50 of 0.30 μM. YQ128 significantly and selectively suppresses the production of IL-1β, but not TNF-α, and it can cross the BBB to reach the CNS. YQ128 has anti-inflammatory activity . YQ128 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-17373S1
CAS. Nr.: 1133712-26-1
Synonyms: SCH 56592-d4
Posaconazole-d4 is a deuterium-labeled form of Posaconazole. Posaconazole is a broad-spectrum, second generation, triazole compound with antifungal activity .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-109127
CAS. Nr.: 1809010-50-1
Reinheit:  98.12%
Synonyms: BCX7353
Target:  

Kallikrein

Forschungsgebiete:  

Cardiovascular Disease Cancer

Berotralstat (BCX7353) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-109127A
CAS. Nr.: 1809010-52-3
Reinheit:  98.49%
Synonyms: BCX7353 dihydrochloride
Target:  

Kallikrein

Forschungsgebiete:  

Cardiovascular Disease Cancer

Berotralstat dihydrochloride (BCX7353 dihydrochloride) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema .
loading...
    loading...
Art. -Nr.: HY-P99625
CAS. Nr.: 2515463-86-0
Synonyms: SAR441344; INX-021

Target:  

TNF Receptor

Frexalimab (SAR441344) is a second-generation monoclonal antibody targeting the CD40 ligand (CD40L) with a good safety profile. Frexalimab inhibits the binding between CD40 and CD40L to modulate immune response. Frexalimab is likely to help prevent the process of β-cell destruction. Frexalimab is proming for multiple sclerosis, lupus erythematosus, Sj gren’s syndrome and type I diabetes research .
loading...
    loading...
Art. -Nr.: HY-B0458
CAS. Nr.: 121123-17-9
Target:  

Antibiotic Bacterial

Forschungsgebiete:  

Infection

Cefprozil monohydrate is a second-generation cephalosporin type antibiotic. Cefprozil monohydrate exhibits broad-spectrum antibacterial activity, and is orally active. Cefprozil monohydrate can be used for the study of pharyngitis, tonsillitis, otitis media, and uncomplicated skin infections .
loading...
    loading...
Art. -Nr.: HY-111186
CAS. Nr.: 90035-08-8
Reinheit:  99.17%
Synonyms: WL 108366
Forschungsgebiete:  

Others

Flocoumafen (WL 108366) is an orally active vitamin K epoxide reductase inhibitor and a multi-target ligand, which includes prostaglandin F synthase, serum albumin, glucocorticoid receptor 2, and MMP-9. Flocoumafen is a second-generation anticoagulant rodenticide (ARs) with a half-life of 177.4 hours and has deadly anticoagulant effects .
loading...
    loading...